Showing 141-150 of 8666 results for "".
How Do You Educate Patients about Chronic Blushing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-do-you-educate-patients-about-chronic-blushing/19825/Dr. Friedman tackles "a doozy of a question" with advice on how to educate patients about signaling gone awry and strategies for long-term care.Hoya ConBio - Non-ablative Skin Rejuvination for Wrinkles and Acne Scars
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-non-ablative-skin-rejuvination-for-wrinkles-and-acne-scars/19459/A study with Dr. Paul Friedman reveals why the Medlite C6 is fast becoming the laser of choice for skin renewal. How to use the Medlite is discussed and demonstrations are shown.Hype v. Hope: Cannabinoids in Dermatology
https://practicaldermatology.com/topics/psoriasis/hype-v-hope-cannabinoids-in-dermatology/19686/Integrative dermatology is growing, along with interest in the potential use of cannabinoids in dermatology. Peter Lio, MD addresses the science and the limitations of CBD.Physician Spotlight: Andrew C. Krakowski, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-andrew-c-krakowski-md/20842/Collagen in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/collagen-atopic-dermatitis/27167/Kripa Ahuja, MS, and Peter Lio, MD, review a 2024 study from Szalsus et al. looking at the role of collagens in atopic dermatitis (AD).How Does Consideration of the Microbiome Affect Topical Product Selection
https://practicaldermatology.com/topics/atopic-dermatitis/how-does-consideration-of-the-microbiome-affect-topical-product-selection/19827/A healthy microbiome is a hallmark of healthy skin, while dysbiosis is implicated in various dermatologic diseases. Dr. Friedman explains how this knowledge should influence topical skin care.Atopic Dermatitis: The Critical Need for Treatment
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-the-critical-need-for-treatment/19668/The therapeutic landscape for atopic dermatitis is expanding, as is understanding of the disease and its impact. More than ever, patients need access to effective therapies and meaningful symptom control strategies, says Adam J. Friedman, MD.Buyer Beware: CBD Products May Peddle False Hope Amid Corona Fears
https://practicaldermatology.com/series/dermatology-dispatches/buyer-beware-cbd-products-may-peddle-false-hope-amid-corona-fears/19775/Any claims that a medical cannabinoid-based product can kill COVID-19 are “absolutely unsubstantiated,” warns Adam Friedman, MD. There is no evidence that these products contain any antiviral properties, and patients should be advised against believing such claims.What’s Growing in Pattern Hair Loss Care?
https://practicaldermatology.com/topics/hair-nails/whats-growing-in-pattern-hair-loss-care/23934/Peter Panagotacos, MD, provides expert advice for surgical and nonsurgical options for treating androgenetic alopecia.Is There Evidence that Topical Formulations Can Support the Microbiome?
https://practicaldermatology.com/topics/atopic-dermatitis/is-there-evidence-that-topical-formulations-can-support-the-microbiome/19826/There is a growing body of research on the importance of the microbiome as well as the potential to support a healthy microbiome through topical product selection, Dr. Friedman says.